Nurettin Ay1, Mehmet Veysi Bahadır2, Melih Anıl3, Vahhac Alp1, Şafak Kaya4, Utkan Sevük5, Mesut Gül2, Ramazan Danış3. 1. Diyarbakir Education and Research Hospital, Transplantation Center Diyarbakir, Turkey. 2. Department of General Surgery, Dicle University Education and Research Hospital Diyarbakir, Turkey. 3. Department of Nephrology, Diyarbakır Gazi Yaşargil Education and Research Hospital Diyarbakır, Turkey. 4. Department of Infectious Disease, Diyarbakır Gazi Yaşargil Training and Research Hospital Diyarbakır, Turkey. 5. Department of Cardiovascular Surgery, Diyarbakır Gazi Yaşargil Education and Research Hospital Diyarbakır, Turkey.
Abstract
OBJECTIVES: There are studies that show that double J stenting (DJS) increase BK nephropathy (BKN) 4 fold. DJS may cause vesicoureteral reflux (VUR) with normal bladder contraction. The aim of this study is to comparison risk of BKN, urinary tract infections (UTI) and postoperative urologic complications with the use DJS with anti-reflux device (ARD-DJS) and standart double J stent (St-DJS). Matherial and methods: Ninety patients (male/female: 50/40) that had undergone kidney transplantations in Diyarbakır Training and Research Hospital and Dicle University, Faculty of Medicine Hospital between January 2012 and April 2015 were enrolled in the study. Demographic data, immunosuppression protocols, presence of rejection, graft loss, postoperative urologic complications, UTI, plasma BK levels of the patients were evaluated retrospectively. RESULTS: Median and IQR follow up time for ARD-DJS and St-DJS patients were 14 (12-18) months and 25 (16-30) months respectively. Five cases (5.5%) had BK viremia (P=0.025). All 5 cases with BK viremia were St-DJS users. CONCLUSION: As a result for postoperative UTI and postoperative urinary complication risk there were no statistically significant difference between ARD-DJS use and St-DJS use during ureteral anastomosis. BKN univariate analysis were significantly less than those st-DJS used. Risc factors were evaluated. But results were not statistically significant in the logistic regression analysis. We think that to demonstrate this benefit, we need randomized controlled studies with more patients and longer follow up.
OBJECTIVES: There are studies that show that double J stenting (DJS) increase BK nephropathy (BKN) 4 fold. DJS may cause vesicoureteral reflux (VUR) with normal bladder contraction. The aim of this study is to comparison risk of BKN, urinary tract infections (UTI) and postoperative urologic complications with the use DJS with anti-reflux device (ARD-DJS) and standart double J stent (St-DJS). Matherial and methods: Ninety patients (male/female: 50/40) that had undergone kidney transplantations in Diyarbakır Training and Research Hospital and Dicle University, Faculty of Medicine Hospital between January 2012 and April 2015 were enrolled in the study. Demographic data, immunosuppression protocols, presence of rejection, graft loss, postoperative urologic complications, UTI, plasma BK levels of the patients were evaluated retrospectively. RESULTS: Median and IQR follow up time for ARD-DJS and St-DJSpatients were 14 (12-18) months and 25 (16-30) months respectively. Five cases (5.5%) had BK viremia (P=0.025). All 5 cases with BK viremia were St-DJS users. CONCLUSION: As a result for postoperative UTI and postoperative urinary complication risk there were no statistically significant difference between ARD-DJS use and St-DJS use during ureteral anastomosis. BKN univariate analysis were significantly less than those st-DJS used. Risc factors were evaluated. But results were not statistically significant in the logistic regression analysis. We think that to demonstrate this benefit, we need randomized controlled studies with more patients and longer follow up.
Entities:
Keywords:
BK nephropathy; Double J stenting; anti-reflux device
Authors: C E H Barber; T J C Hewlett; L Geldenhuys; B A Kiberd; P D Acott; T F Hatchette Journal: Transpl Infect Dis Date: 2006-06 Impact factor: 2.228
Authors: L F C Dols; T Terkivatan; N F M Kok; T C K Tran; W Weimar; J N M IJzermans; J I Roodnat Journal: Transplant Proc Date: 2011-06 Impact factor: 1.066
Authors: Ajit P Limaye; Kelly D Smith; Linda Cook; Debra A Groom; Nicholas C Hunt; Keith R Jerome; Michael Boeckh Journal: Am J Transplant Date: 2005-03 Impact factor: 8.086
Authors: Panco Georgiev; Christian Böni; Felix Dahm; Christine F Maurus; Stefan Wildi; Valentin Rousson; Rudolf P Wüthrich; Pierre-Alain Clavien; Markus Weber Journal: Urology Date: 2007-10-24 Impact factor: 2.649